Trial · NCT07891026
Cumulative Intra-Abdominal Pressure Burden and Acute Kidney Injury After Emergency Abdominal Surgery
NCT07891026, Not yet recruiting, Ugur Duman
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Cumulative Intra-Abdominal Pressure Burden and Acute Kidney Injury After Emergency Abdominal Surgery. Trials, record NCT07891026. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07891026
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Cumulative Intra-Abdominal Pressure Burden and Acute Kidney Injury After Emergency Abdominal Surgery
- NCT number
- NCT07891026
- Status
- Not yet recruiting
- Enrollment
- 300 participants, estimated
- Lead sponsor
- Ugur Duman
- Conditions
- Acute Kidney Injury, Intra-Abdominal Hypertension
- Interventions
- Serial Intra-Abdominal Pressure Measurement
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of Acute Kidney Injury Within Seven Postoperative Days | From surgery completion (day 0) through postoperative day 7 | The proportion of participants who develop acute kidney injury (AKI) within seven days following emergency abdominal surgery. AKI will be defined and staged according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria using changes in serum creatinine concentrations and urine output. |
| Secondary | Incidence of KDIGO Stage 2 or 3 Acute Kidney Injury | From surgery completion (day 0) through postoperative day 7 | The proportion of participants who develop moderate to severe acute kidney injury, defined as KDIGO stage 2 or stage 3, based on serum creatinine changes and urine output criteria. |
| Secondary | Incidence of Oliguria | From surgery completion (day 0) through postoperative day 7 | The proportion of participants who develop oliguria during postoperative monitoring. Urine output will be assessed using hourly urine output measurements and evaluated according to KDIGO urine output criteria. |
| Secondary | Requirement for Renal Replacement Therapy | From postoperative intensive care unit admission (day 0) until intensive care unit discharge or death, whichever occurs first, assessed up to 28 days | The proportion of participants requiring renal replacement therapy during the postoperative intensive care period, including continuous or intermittent renal replacement modalities. |
| Secondary | Intensive Care Unit Mortality | From postoperative intensive care unit admission (day 0) until intensive care unit discharge or death, whichever occurs first, assessed up to 28 days | The proportion of participants who die from any cause during the postoperative intensive care unit stay. |
| Secondary | Intensive Care Unit Length of Stay | From postoperative intensive care unit admission (day 0) until intensive care unit discharge or death, whichever occurs first, assessed up to 28 days. | Duration of postoperative intensive care unit stay, measured in days from intensive care unit admission until discharge or death. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07891026
GET https://conductscience.org/api/trials/v1/NCT07891026/registered